Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Albemarle outlines Rivanna Futures plan as AstraZeneca commits to 82 acres; ARB forwards Land Bay 82 initial plan
Summary
County staff gave the ARB a detailed Rivanna Futures update tied to AstraZeneca’s selection of roughly 82 acres and a $4.5 billion capital investment; the board forwarded the Land Bay 82 initial site plan to the site-review agent with staff recommendations, and staff described grants, a $42 million road estimate and a tight schedule to complete grant-funded site readiness.
Albemarle County staff on Jan. 20 briefed the Architectural Review Board on the county’s Rivanna Futures property and the early-stage plans tied to AstraZeneca’s proposed manufacturing campus, and the board voted to forward the Land Bay 82 initial site plan to the site-review agent with no modifications.
Emily Kilroy, identified in the meeting as the county’s director of economic development, said Rivanna Futures is the county-owned property adjacent to Rivanna Station and totals about 463 acres in county ownership, with a rezoned subset of approximately 172 acres for light industrial/office uses. Kilroy said AstraZeneca plans to acquire roughly 82 acres within that rezoned area for a two-facility manufacturing campus and that the company expects to employ about 600 people directly at the two specialized production facilities. Kilroy described the investment as a major economic development prospect for the county and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
